《亞洲股市》日經半日反覆續跌42點 衛采飆9.1% 圓匯139.86
美股隔晚(7日)個別發展,道指靠穩,不過科技股見沽壓,標普及納指由升轉跌。日經指數今早(8日)反覆偏軟,低開35點後,早市一度倒升122點,高見32,035,惟高位未能企穩,半日收報31,871,跌42點或0.13%,暫延續上日跌勢。美元兌日圓報139.86。
主要銀行股溫和回升,三菱日聯、Resona控股及三井住友升0.6%至0.8%,瑞穗升1%。
主要車股日產及三菱汽車微升0.3%至0.8%,豐田升1.3%。
權重股個別發展,樂天及軟銀微跌0.2%至0.4%,Sony及Z Holdings各跌1%,迅銷微升,瑞薩電子及石油股ENEOS升1.2%至1.5%,東京電力揚5.4%。三大航運股商船三井、日本郵船及川崎汽船升2%至3%。
醫藥股衛采半日飆9.1%,美國食藥監局(FDA)官員周三(7日)指衛采與渤健(BIIB.US)合作開發的阿茲海默症藥後期階段臨床的數據,反映對患者有顯著益處,安全憂慮料不會削弱獲傳統批准的機會。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.